Growing Preference for Combination Therapy and Non-surgical Aesthetic Procedures to Boost Global Facial Injectable Market Revenue

Wednesday, November 28, 2018 Anti-Aging News
Email Print This Page Comment bookmark
Font : A-A+

NEW YORK, November 28, 2018 /PRNewswire/ --

Celebrity Endorsements to Elevate

Use of Botox Treatments Among the General Population 

Globally, the market for facial injectable is witnessing a sudden boom, given the massive leverage by celebrities to enhance their facial skin using non-surgical

alternatives. The growing global obsession over elimination of dark circles, uplifting of eyebrows, enhancement of cheekbones, reduction of wrinkles, and overall smoothening of facial skin is pushing revenues in the global market for facial injectable. A recent study conducted by experts at premier market research firm Persistence Market Research on the facial injectable market reveals the following interesting insights:

  • Combination therapy continues to dominate the preferences of surgeons to offer personalized treatments - the application of botulinum toxin type-A (Botox, Xeomin, or Dysport) along with dermal fillers being the most sought after procedure to reduce wrinkles and restore volume to the skin.
  • Facial injectable treatment options are increasingly being adopted by people in the U.S owing to the growing awareness of and information on various procedures.

     (Logo: )

Request Sample Report @

  • The rising preference for non-surgical aesthetic alternatives especially in the case of patients who are not fit for plastic surgery is leading to a surge in demand for facial injectable.
  • Celebrity endorsements promoting various facial injectable treatments are benefitting the global market by pushing revenue at a significant rate.
  • Social media is a top channel used by players in the facial injectable market to reach a wider customer base and create enhanced awareness.    

Market for Botox to Expand Significantly in the Asia Pacific Region  

Consumers in countries of the Asia Pacific seem to be exhibiting a unanimous preference for botulinum toxin, given the high demand generation from the region. Among the few companies in the facial injectable market engaged in the production of botulinum toxin, three key manufacturers are based in Korea to cater to the burgeoning demand from the Asia Pacific market. Additionally, a slew of facial injectable products manufactured by local unauthorized companies are also widely sold in the Asia Pacific market, indicating the growing number of treatments incorporating facial injectable products.

Facial Injectable Market Research Report Overview @

"To gain an edge over competition and to expand into top international markets, key players in the Asia Pacific facial injectable market are collaborating and partnering with other players to strengthen their regional and subsequently global manufacturing and distribution network of facial injectable products, particularly botulinum toxin." -- Practice Head - Medical Devices, Persistence Market Research

Analysts at Persistence Market Research have forecasted a significant absolute dollar opportunity for the global facial injectable market at US$ 279.6 Mn in 2019 over 2018 and a 10-year incremental opportunity of US$ 3516.09 Mn between 2018 and 2028. With global revenues pegged at US$ 6,131.6 Mn by 2018 end, the facial injectable market is projected to register Y-o-Y growth of 2.3% between 2018 and 2019.

This comprehensive Persistence Market Research study on the global facial injectable market throws light on the critical market revenue pull factors, threatening widespread adoption of facial injectable treatments and products.

Download and View Report TOC, Figures and Tables @

High procedural costs to negatively impact revenue. Facial injectable treatments are expensive with physician/surgeon costs almost half the cost of the actual treatment. Further, these treatments typically require multiple sessions to obtain the desired results. This adds up the cost factor to a significant extent. As such, facial injectable treatments are not affordable by all classes of the population. This is a primary revenue restraint in the global market for facial injectable.

Side effects of facial injectable treatments to pull the plug on market growth. Treatments involving Botox and dermal fillers lead to certain adverse side effects such as redness and bruising of the skin, allergic reactions, and a certain level of discomfort associated with the treatment. This is a major revenue dampener in the facial injectable market, with people shying away from expensive Botox treatments for fear of adverse reactions.

Get full Report Now @

Other restraints negatively impacting revenue growth include the availability of cheap counterfeit facial injectable products and very low reimbursement coverage associated with facial injectable treatments.

More from PMR's Life Sciences & Transformational Health Market Intelligence:

Elder Care Services Market segmentation: By Service Type- Home-based Care, Community-based Care, Institutional Care; By Financing Source: Public Expenditure, Private Source, Out-of-Pocket Spending:

Medical Marijuana Market Segmentation: product type - Dried Form, Extract Form; application type- Pain management; Seizures, Others; distribution channel - Retail Pharmacy, E-Commerce: Wearable Injectors Market : segmented by product type- Body-worn patch injectors,Off-body worn injectors; By distribution channels - Hospital Pharmacies,Retail Pharmacies, Online sales and others:

Persistence Market Research Overview 

Persistence Market Research (PMR) is a third-platform research firm. Our research model is a unique collaboration of data analytics and market research methodology to help businesses achieve optimal performance.

To support companies in overcoming complex business challenges, we follow a multi-disciplinary approach. At PMR, we unite various data streams from multi-dimensional sources. By deploying real-time data collection, big data, and customer experience analytics, we deliver business intelligence for organizations of all sizes.

Contact Persistence Market Research U.S. Sales Office: 305 Broadway, 7th Floor New York City, NY 10007 +1-646-568-7751 United States USA - Canada Toll-Free: 800-961-0353 Email:

PMR Latest News:

SOURCE Persistence Market Research Pvt. Ltd.

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z


News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store